Pharvaris NV
0.71 (10.49%)
Company Name Stock Ticker Symbol Market Type
Pharvaris NV PHVS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.71 10.49% 7.48 16:14:30
Open Price Low Price High Price Close Price Prev Close
7.09 7.09 7.53 7.48 6.77
more quote information »

Recent News

Date Time Source Heading
3/18/202300:35GLOBEPositive Phase 2 Data from RAPIDe-1 Study of PHVS416 for the..
3/10/202316:43EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/02/202306:50GLOBEPharvaris to Present in Upcoming March Investor Conferences
2/24/202306:50GLOBEPharvaris to Highlight Positive Phase 2 Data from RAPIDe-1..
2/14/202313:19EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202307:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/13/202316:57EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202312:09EDGARAmended Statement of Ownership (sc 13g/a)
2/08/202306:50GLOBEPharvaris to Present at SVB Securities Global Biopharma..
1/09/202306:50GLOBEPharvaris Provides Regulatory, Clinical, and Corporate..
12/12/202206:35TRMNSVB Securities Remains a Buy on Pharvaris (PHVS)
12/09/202200:45TRMNPharvaris (PHVS) Receives a Buy from JMP Securities
12/08/202211:37TRMNPharvaris Soars After Positive Topline Data
12/08/202210:35DJNPharvaris Shares Soar 79% on Hereditary Angioedema Treatment..
12/08/202208:03EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/08/202206:52EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/08/202206:51GLOBEPharvaris Reports Third Quarter 2022 Financial Results and..
12/08/202206:50GLOBEPharvaris Announces Positive Top-line Phase 2 Data from..
11/10/202208:00GLOBEPharvaris to Present PHVS416 and PHVS719 Clinical Data for..
11/02/202200:55TRMNJMP Securities Sticks to Its Buy Rating for Pharvaris (PHVS)
10/07/202208:30GLOBEPharvaris Presents Data Supporting HAE Drug Development..
9/30/202206:50GLOBEPharvaris Announces the Promotion of Annick Deschoolmeester..
9/29/202200:25TRMNPharvaris (PHVS) Gets a Buy from JMP Securities
9/16/202204:45GLOBEPharvaris Highlights Data Supporting Clinical Development..
9/13/202223:46TRMNSVB Securities Keeps Their Buy Rating on Pharvaris (PHVS)
9/13/202200:45TRMNJMP Securities Initiates a Buy Rating on Pharvaris (PHVS)
9/12/202206:52EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/12/202206:50GLOBEPharvaris Reports Second Quarter 2022 Financial Results and..
8/22/202207:36DJNPharvaris: FDA Has Placed U.S. Angioedema Trials on Clinical..
8/22/202206:50GLOBEPharvaris Announces FDA Clinical Hold on PHA121 Clinical..
7/14/202208:10GLOBEPharvaris to Participate in H.C. Wainwright 1st Annual..
7/13/202206:52EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/06/202208:10GLOBEPharvaris to Host Virtual Expert Perspectives on HAE: Unmet..
6/14/202208:10GLOBEPharvaris Announces Annual Meeting of Shareholders
6/07/202208:10GLOBEPharvaris Participates in the Kinin 2022 Conference
5/17/202222:38TRMNPharvaris (PHVS) Gets a Buy Rating from SVB Securities
5/17/202208:44TRMNPharvaris (PHVS) Receives a Buy from Morgan Stanley
5/16/202208:10GLOBEPharvaris Supports HAE Community by Participating in..
5/11/202208:15GLOBEPharvaris Appoints Joan Schmidt, J.D., as Chief Legal..
5/11/202208:10GLOBEPharvaris Reports First Quarter 2022 Financial Results and..
5/11/202208:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/05/202216:10GLOBEPharvaris to Participate in BofA Securities 2022 Healthcare..
4/06/202216:10GLOBEPharvaris to Participate in Upcoming April Investor..
3/30/202210:31TRMNPharvaris (PHVS) Receives a Buy from Leerink Partners
3/29/202209:00SEEKPharvaris GAAP EPS of -€0.41
3/29/202208:10EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/29/202208:10GLOBEPharvaris Reports Fourth Quarter and Full Year 2021..
3/29/202208:02EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
Your Recent History
Pharvaris ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230326 00:38:15